RCW 69.04.510
161 words·~1 min read·
/wa/title-69/chapter-69-04/69-04-510·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
A drug or device shall be deemed to be misbranded if it purports to be a drug the name of which is recognized in an official compendium, unless it is packaged and labeled as prescribed therein: PROVIDED, That the method of packing may be modified with the consent of the director, as permitted under section 502(g) of the federal act. Whenever a drug is recognized in both the United States pharmacopoeia and the homeopathic pharmacopoeia of the United States, it shall be subject to the requirements of the United States pharmacopoeia with respect to packaging and labeling unless it is labeled and offered for sale as a homeopathic drug, in which case it shall be subject to the provisions of the homeopathic pharmacopoeia of the United States, and not to those of the United States pharmacopoeia.
[ 1945 c 257 s 69 ; Rem. Supp. 1945 s 6163-118. Prior: 1923 c 36 s 2 ; 1907 c 211 s 4 .]